In stable COPD patients, serum and sputum IL-17 levels are significantly higher than in healthy controls and rise further during acute exacerbations (AECOPD), indicating that IL-17 is not only associated with persistent inflammation in COPD but may also serve as a biomarker for disease progression (165). The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.